Castle Biosciences
CSTL
CSTL
157 hedge funds and large institutions have $569M invested in Castle Biosciences in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more capital invested
Capital invested by funds: $491M → $569M (+$77.9M)
8% more funds holding
Funds holding: 146 → 157 (+11)
2.8% less ownership
Funds ownership: 85.91% → 83.11% (-2.8%)
Holders
157
Holding in Top 10
4
Calls
$5.84M
Puts
$13K
Top Buyers
| 1 | +$7.77M | |
| 2 | +$4.85M | |
| 3 | +$4.26M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$3.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$3.56M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.74M | |
| 3 | -$9.57M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$9.41M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$6.48M |